Inventor · disambiguated record
Emma Suzanne Cohen
Also filed as: COHEN EMMA S · COHEN EMMA SUZANNE
8 granted patents·14 pending applications·17 citations·filing 2007–2024
83Inventor score
Top patents by PatentIndex Score
22 records- 0187US2024124596A1Antibody molecule for human gm-csf receptor alphaMEDIMMUNE LTD·Filed 2023·Application pending·0 cites
- 0284US8263075B2Antibody molecule for human GM-CSF receptor alphaCOHEN EMMA SUZANNE·Filed 2007·Granted Sep 11, 2012·6 cites·10 claims
- 0383US8506960B2Antibody molecule for human GM-CSF receptor alphaCOHEN EMMA SUZANNE·Filed 2007·Granted Aug 13, 2013·5 cites·15 claims
- 0481US10668150B2IL33 form, mutated forms of IL33, antibodies, assays and methods of using the sameMEDIMMUNE LTD·Filed 2016·Granted Jun 2, 2020·3 cites·13 claims
- 0578US11738081B2Polynucleotides encoding IL33 antibodies and methods of using the sameMEDIMMUNE LTD·Filed 2020·Granted Aug 29, 2023·1 cites·15 claims
- 0677US9085628B2Antibody molecule for human GM-CSF receptor alphaMEDIMMUNE LTD·Filed 2013·Granted Jul 21, 2015·2 cites·16 claims
- 0774US2021147559A1Antibody molecule for human gm-csf receptor alphaMEDIMMUNE LTD·Filed 2020·Application pending·0 cites
- 0873US12178911B2Dry powder formulations of thymic stromal lymphopoietin (TSLP)-binding antibodies and methods of use thereofMEDIMMUNE LTD·Filed 2022·Granted Dec 31, 2024·0 cites·5 claims
- 0973US2025099386A1Dry Powder Formulations of Thymic Stromal Lymphopoietin (TSLP)-Binding Antibodies and Methods of Use ThereofMEDIMMUNE LTD·Filed 2024·Application pending·0 cites
- 1072US2024016929A1Il33 antibodies and methods of using the sameMEDIMMUNE LTD·Filed 2023·Application pending·0 cites
- 1167US2019309077A1Antibody molecule for human gm-csf receptor alphaMEDIMMUNE LTD·Filed 2019·Application pending·0 cites
- 1265US2019040145A1Antibody molecule for human gm-csf receptor alphaMEDIMMUNE LTD·Filed 2018·Application pending·0 cites
- 1364US9587027B2Methods for binding members of interleukin-4 receptor α (IL-4Rα)MEDIMMUNE LTD·Filed 2014·Granted Mar 7, 2017·0 cites·8 claims
- 1463US2018327502A1BINDING MEMBERS OF INTERLEUKIN-4 RECEPTOR ALPHA (IL4-Ra)MEDIMMUNE LTD·Filed 2018·Application pending·0 cites
- 1562US2025215074A1Methods for reducing respiratory infectionsMEDIMMUNE LTD·Filed 2023·Application pending·0 cites
- 1661US11904053B2Dry powder formulations of thymic stromal lymphopoietin (TSLP)-binding antibodies and methods of use thereofMEDIMMUNE LTD·Filed 2020·Granted Feb 20, 2024·0 cites·19 claims
- 1759US2018057596A1BINDING MEMBERS OF INTERLEUKIN-4 RECEPTOR ALPHA (IL4-Ra)MEDIMMUNE LTD·Filed 2017·Application pending·0 cites
- 1857US2015376285A1Antibody Molecule For Human GM-CSF Receptor AlphaMEDIMMUNE LTD·Filed 2015·Application pending·0 cites
- 1953US2024199730A1An anti-tslp fab with improved stabilityMEDIMMUNE LTD·Filed 2022·Application pending·0 cites
- 2052US2023174637A1Treating acute respiratory distress syndrome with il-33 axis binding antagonistsMEDIMMUNE LTD·Filed 2021·Application pending·0 cites
- 2150US2022363748A1Anti il-33 therapeutic agent for treating renal disordersMEDIMMUNE LTD·Filed 2020·Application pending·0 cites
- 2246US2022380450A1Methods of using il-33 antagonistsMEDIMMUNE LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Emma Suzanne Cohen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →